MICROPORT EP expects a half-year net profit attributable to the parent company of 30 million to 35 million yuan, an increase of 76.34% to 105.73% year-on-year

MICROPORT EP expects the net profit attributable to the parent company for the first half of 2025 to be between 30 million and 35 million yuan, an increase of 76.34% to 105.73% year-on-year. The company focuses on the field of cardiac electrophysiology and actively expands the atrial fibrillation treatment market, relying on multiple technological advantages. Thanks to the successful promotion of new products overseas, the company's overseas market sales performance has been outstanding, driving significant growth in overall sales and net profit